ADAPALENE 0.1%w/w IP + BENZOYL PEROXIDE 2.5%w/w IP

A topical retinoid and an antimicrobial for the treatment of mild to moderately severe inflammatory acne vulgaris. (Jiang, 2014) Exhibits a potent and rapid bactericidal effect against Propionibacterium acnes and possesses anti-inflammatory, comedolytic, and anti-comedogenic properties. (Jiang, 2014) Prevents the occurrence of relapse among patients with severe acne vulgaris. (Jiang, 2014) Provides significantly greater efficacy for the treatment of acne vulgaris than monotherapies. (Diane M Thiboutot & Group, 2007) Significantly more effective than corresponding monotherapies, with significant differences in total lesion counts. (Diane M Thiboutot & Group, 2007) Attenuates the number of both inflammatory and noninflammatory lesions in subjects with acne vulgaris. (Leyden, 2016) A safe and effective antimicrobial agent that shows a potent and rapid bactericidal effect. (Ochsendorf, 2016) A very valuable drug both in the induction as well as the maintenance therapy for all forms of acne vulgaris. (Ochsendorf, 2016) Offers a faster onset of action with an acceptable safety profile in the treatment of acne vulgaris. (H P M Gollnick & Group, 2009) A safe and effective drug in the long-term management of patients with moderate to severe acne. (H P M Gollnick, 2015) An appropriate medication for long-term usage in patients with moderate to severe facial acne. (H P M Gollnick, 2015)